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A cell and substrate system and nerve regeneration implant 
are disclosed including a carbon nanotube and a neuron 
groWing on the carbon nanotube. Both unfunctionaliZed 
carbon nanotubes and carbon nanotubes functionaliZed With 
a neuronal groWth promoting agent may be utiliZed in the 
invention. A method is also disclosed for promoting neu 
ronal groWth. 
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MOLECULAR FUNCTIONALIZATION OF 
CARBON NANOTUBES AND USE AS 
SUBSTRATES FOR NEURONAL GROWTH 
TECHNICAL FIELD 
The present invention relates generally to the ?elds of 
carbon nanotube technology and neurobiology and, more 
particularly, to a cell and substrate system or nerve regen 
eration implant and to a method for promoting neuronal 
groWth. 
BACKGROUND OF THE INVENTION 
The mammalian nervous system is a complex cellular 
communication netWork that contains over 1011 nerve cells 
or neurons. Each of these neurons has an elaborate mor 
phology including aXons and dendrites that eXtend over long 
distances. These aXons and dendrites are collectively knoWn 
as neurites. Synapses are the point at Which a nervous 
impulse passes from one neuron to another. The groWth of 
neurites and the formation of synapses during development 
and regeneration is controlled by highly motile structural 
specialiZation at the tip of the neurite called the groWth cone. 
Our ability to develop advances in technology to alloW 
better regeneration and restoring of function of damaged 
neuronal circuits Will ?rst require a heightened understand 
ing of groWth cone physiology. 
Presently the studying of mechanisms that regulate neu 
rite outgroWth generally employ cultures of disassociated 
neurons from brains or spinal cords of embryonic rodents. 
Speci?cally, the neurons are seeded into dishes having a 
culture surface that has been coated With a uniform layer of 
adhesive molecules that promote neurite outgroWth. 
Although studies using this approach have led to the iden 
ti?cation of a number of molecules that promote or inhibit 
neurite outgroWth, this approach does not alloW for the 
manipulating of the groWth environment at the nanometer 
scale. Accordingly, many mysteries of the groWth mecha 
nism remain. 
A need is therefore identi?ed for a means of studying 
neurite outgroWth at the nanometer scale. The present inven 
tion relates to a cell and substrate system and a method for 
promoting neuronal groWth Which Will alloW completion of 
these studies as Well as to an implant for effectively pro 
moting nerve regeneration. 
SUMMARY OF THE INVENTION 
In accordance With the purposes of the present invention 
as described herein, a cell and substrate system or nerve 
regeneration implant is provided. This system/implant com 
prises a carbon nanotube and a neuron groWing on that 
carbon nanotube. 
The carbon nanotube has a diameter of about 1.0—100.0 
nm and a length of betWeen about 20—100 pm. In one 
embodiment the carbon nanotube is functionaliZed With a 
neuronal groWth promoting agent. That neuronal groWth 
promoting agent may be selected from a group consisting of 
4-hydroXynonenal, acetylcholine, dopamine, GABA 
(g-aminobutyric acid), glutamate, serotonin, somatostatin, 
nitrins, semaphorins, roundabout, calcium (Ca2+) miXtures 
thereof. 
In accordance With yet another aspect of the present 
invention a method is provided for promoting neuronal 
groWth. That method may be broadly described as including 
the step of groWing a neuron on a carbon nanotube. 
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In accordance With one embodiment of the invention the 
method may include the step of functionaliZing the carbon 
nanotube With a neuronal groWth promoting agent. That 
agent may be selected from a group consisting of 
4-hydroXynonenal, acetylcholine, dopamine, GABA 
(g-aminobutyric acid), glutamate, serotonin, somatostatin, 
nitrins, semaphorins, roundabout, calcium (Ca2+) miXtures 
thereof. 
The functionaliZing step may include the step of sonicat 
ing the carbon nanotubes in an acid solution containing the 
neuronal groWth promoting agent. 
The method further includes the step of applying the 
functionaliZed carbon nanotube to a glass coverslip. This is 
folloWed by the placing of the glass coverslip and attached 
functionaliZed carbon nanotube in a culture dish With a 
culture medium suitable for supporting the groWth of neu 
ronal cells. This is folloWed by the seeding of a neuronal cell 
into the culture dish. 
The bene?ts and advantages of the present invention Will 
become readily apparent to those skilled in this art from the 
folloWing description Wherein there is shoWn and described 
preferred embodiments of this invention, simply by Way of 
illustration of various modes best suited to carry out the 
invention. As it Will be realiZed, the invention is capable of 
other different embodiments, and its several details are 
capable of modi?cation in various, obvious aspects all 
Without departing from the invention. Accordingly, the 
draWing and descriptions Will be regarded as illustrative in 
nature and not as restrictive. 
BRIEF DESCRIPTION OF THE DRAWING 
The accompanying draWing incorporated in and forming 
a part of this speci?cation, illustrates several aspects of the 
present invention, and together With the description serves to 
explain the principles of the invention. In the draWing: 
FIG. 1 is a schematical illustration shoWing a group of 
neuronal cells groWing on some carbon nanotubes attached 
to a glass coverslip held in a culture dish With a culture 
medium; and 
FIG. 2 is a graphical illustration shoWing the numbers of 
neurites/neuron, total neurite length/neuron and numbers of 
branches/neurite in neurons groWn on carbon nanotubes 
coated With 4-hydroXynonenal and neurons groWn on con 
trol nanotubes Without any functionaliZation and nanotubes 
reacted With 4-hydroXynonenal that had been pre-incubated 
With a 100-fold molar eXcess of histidine. 
Reference Will noW be made in detail to the present 
preferred embodiment of the invention, an eXample of Which 
is illustrated in the accompanying draWing. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The present invention relates to a cell and substrate 
system or a nerve regeneration implant comprising a carbon 
nanotube 10 and a neuron 12 groWing on that carbon 
nanotube. Typically carbon nanotubes 10 utiliZed in the 
present invention have a diameter of about 1.0—100.0 nm 
and a length of betWeen about 20—100 pm. 
In accordance With an additional aspect of the present 
invention, the carbon nanotube 10 may be functionaliZed 
With a neuronal groWth promoting agent. The neuronal 
groWth promoting agent may be selected from a group 
consisting of 4-hydroXynonenal, acetylcholine, dopamine, 
GABA (g-aminobutyric acid), glutamate, serotonin, 
somatostatin, nitrins, semaphorins, roundabout, calcium 
(Ca2+) miXtures thereof. 
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Reference Will noW be made to FIG. 1 Which illustrates 
the method of the present invention for promoting neuronal 
groWth. That method may be broadly de?ned as including 
the step of growing a neuron 12 on a carbon nanotube 10. In 
accordance With a further aspect of the present invention the 
method may incorporate the step of functionaliZing that 
carbon nanotube 10 With a neuronal groWth promoting agent 
such as 4-hydroxynonenal, acetylcholine, dopamine, GABA 
(g-aminobutyric acid), glutamate, serotonin, somatostatin, 
nitrins, semaphorins, roundabout, calcium (Ca2+) mixtures 
thereof. 
More speci?cally describing the invention, multiWalled 
nanotubes 10 are synthesiZed in accordance With any appro 
priate method knoWn in the art such as via catalytic decom 
position of a ferrocene-xylene mixture. (AndreWs R., 
Jacques D., Rao A. M., Derbyshire F., Qian D., Fan X., et al. 
(1999) Continuous production of aligned carbon nanotubes: 
a step closer to commercial realiZation. Chem. Phys. Lett. 
303, 467). The nanotubes 10 are sonicated in a bath of 100% 
ethanol or other appropriate solvent and the dispersed nano 
tubes are then applied to glass coverslips 14 that are coated 
With a thin layer of polyethyleneimine or other appropriate 
neuronal groWth promoting agent. The ethanol is then 
alloWed to evaporate under ambient conditions. This serves 
to formally adhere the carbon nanotubes 10 to the coverslips 
14. The coverslips 14 are then placed into plastic culture 
dishes 16. The coverslips 14 and dishes 16 are then steriliZed 
by any appropriate means such as 5-minute exposure to UV 
light and an appropriate culture medium 18 is added to the 
dishes. 
Next is the seeding of neuronal cells in the culture dish. 
The neurons 12 may then be groWn in the culture dish 16 on 
the carbon nanotubes 10 for up to eight or more days since 
the nanotubes support long-term cell survival. 
Neurons 12 groWn on unfunctionaliZed carbon nanotubes 
10 permit neurite outgroWth and the carbon nanotubes do 
not appear to in?uence the direction of the groWth. The 
neurites tend to groW straight across the surfaces of the 
carbon nanotubes arranged in various orientations With 
respect to the direction of neurite outgroWth. Where neurites 
greW across carbon nanotubes 10 and then on to the poly 
ethyleneimine coated glass coverslips 14, the neurites typi 
cally do not form branches on the nanotubes but did form 
branches on the coverslips. Thus, neurites groWn on unfunc 
tionaliZed carbon nanotubes 10 tend to be relatively uncon 
ducive to branch formation. 
In order to groW neurons 12 With enhanced neurite 
branching and total neurite outgroWth, the carbon nanotubes 
10 may ?rst be functionaliZed With a neuronal groWth 
promoting agent such as 4-hydroxynonenal, acetylcholine, 
dopamine, GABA (g-aminobutyric acid), glutamate, 
serotonin, somatostatin, nitrins, semaphorins, roundabout, 
calcium (Ca2+) mixtures thereof. 
ToWard this end, the carbon nanotubes 10 may be initially 
dispersed by soni?cation in 100% ethanol. The dispersed 
carbon nanotubes 10 are then incubated in an acidic solution, 
approximate pH 5.0, of 50% ethanol at a concentration of, 
for example, 4 mg of carbon nanotubes per mL containing 
the neuronal groWth promoting agent. The mixture is soni 
cated for an appropriate time (eg 20 min.) in a bath 
sonicator and the carbon nanotubes 10 are then recovered 
and applied to glass coverslips 14 coated With 
polyethyleneimine, a substrate for neuronal groWth. The 
coverslips 14 are then Washed extensively With, for example, 
a phosphate-buffered saline, steriliZed such as by exposure 
to UV light for, for example, ?ve minutes, and placed in 
culture dishes 16 containing an appropriate culture medium 
18. 
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This is folloWed by the seeding of the glass coverslips 14 
in the culture dish With neuronal cells 12. The neuronal cells 
12 are then groWn on the functionaliZed carbon nanotubes 
10 for eight or more days in culture. The resulting product 
may be used as a cell and substrate system for the study of 
neurons and particularly the groWth cone of neurons 12 at 
the nanometer scale or even as a nerve regeneration implant. 
In addition, since carbon nanotubes 10 are excellent elec 
trical conductors, the cell and substrate system of the present 
invention is expected to prove valuable for electro 
physiological analyses of neuronal microcircuitry. 
More speci?cally, carbon nanotubes of de?ned diameters 
ranging from 1 nm to 100 nm may noW be routinely 
produced. These diameters are similar to those of small 
nerve ?bers, groWth cone ?lopodia and synaptic contacts. 
Accordingly, neurons groWn on carbon nanotubes encounter 
an environment that resembles in some Way cell surfaces 
and extra-cellular matrix structures that neurons encounter 
in vivo. Thus, it is believed that the nerve regeneration 
implants of the present invention Will be particularly useful 
and effective in regenerating and/or restoring the function of 
damaged neuronal circuits. 
The folloWing example is presented to further illustrate 
the invention, but it is not to be considered as limited thereto. 
In the examples, the multiWalled carbon nanotubes utiliZed 
Were synthesiZed via the catalytic decomposition of a 
ferrocene-xylene mixture as described in the article entitled 
“Continuous Production of Aligned Carbon Nanotubes: A 
Step Closer to Commercial Realization” by AndreWs et al. 
noted above. The primary hippocampal cell cultures utiliZed 
Were established from E18 rat embryos using methods 
described previously. (Mattson M. P. (1988) Neurotransmit 
ters in the regulation of neuronal cytoarchitecture. Brain 
Res. Rev. 13, 179—212). The multi-Walled carbon nanotubes 
utiliZed in the examples had diameters of approximately 20 
nm and lengths of 20—100pM. These carbon nanotubes Were 
produced as sheets in Which the nanotubes Were arranged in 
parallel array. 
The dissociated cells Were seeded onto 
polyethyleneimine-coated 22 mm2 glass coverslips and 
incubated in neurobasal medium containing B-27 supple 
ments (Gibco-BRL) plus 2 mM L-glutamine, 1 mM HEPES, 
and 0.001% gentamicin sulfate (Sigma). 
All cultures in the example Were examined and photo 
graphed using a light microscope With phase-contrast optics 
and some of the cultures Were prepared for examination With 
a scanning electron microscope (SEM). 
UnfunctionaliZed carbon nanotubes Were dispersed by 
bath sonication for 5 min in 100% ethanol. The dispersed 
nanotubes Were applied to 22 mm2 glass coverslips that had 
been coated With a thin layer of polyethyleneimine. The 
ethanol Was alloWed to evaporate under ambient conditions, 
resulting in ?rm adherence of the nanotubes to the cover 
slips. The coverslips Were then placed in 33-mm diameter 
plastic-culture dishes, steriliZed by a 5-min exposure to UV 
light, and culture medium Was added to the dishes. The next 
day dissociated embryonic rat hippocampal neurons Were 
seeded into the cultures. Adhesion of 4-hydroxynonenal ( 
4-HNE) to nanotubes Was accomplished by ?rst dispersing 
the nanotubes in 100% ethanol, and then incubating the 
dispersed nanotubes in an acidic solution, pH 5.0, of 50% 
ethanol (4 mg nanotubes/mL) containing 200 pM 4-HNE 
(Cayman Chemical Co The mixture Was then sonicated for 
20 min in a bath sonicator, and nanotubes Were applied to 
polyethyleneimine-coated glass coverslips. The coverslips 
Were then Washed extensively With phosphate-buffered 
US 6,670,179 B1 
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saline (PBS), sterilized by exposure to UV light for 5 min, 
and placed in culture dishes containing medium. 
In order to determine Whether 4-HNE Was bound to the 
nanotubes, an antibody against 4-HNE Was employed. 
(Waeg G., Dimsity G., and Esterbauer H. (1996) Mono 
clonal antibodies for detection of 4-hydroxynonenal modi 
?ed proteins. Free Rad. Res. 25, 149—159; Mattson M. P., Fu 
W., Waeg G., and Uchida K. (1997) 4-hydroxynonenal, a 
product of lipid peroxidation, inhibits dephosphorylation of 
the microtubule-associated protein tau. NeuroReport 8, 
2275—2281.) Examination of the nanotubes using confocal 
laser-scanning microscopy and SEM shoWed that 4-HNE 
antibody bound strongly to the nanotubes that had been 
reacted With 4-HNE; but not to untreated nanotubes or to 
nanotubes reacted With 4-HNE that had been preincubated 
With a 100-fold molar excess of histidine. 4-HNE Was 
present along the length of the nanotubes. These ?ndings 
demonstrate a physical association of 4-HNE With the 
nanotubes under the conditions employed. 
We next cultured embryonic hippocampal neurons on 
nanotubes coated With 4-HNE, and on control nanotubes 
that Were either untreated or reacted With 4-HNE that had 
been preadsorbed With excess histidine. SEM examination 
suggested that neurons groWn on nanotubes modi?ed With 
4-HNE had more elaborate neuritic arbors than did neurons 
groWn on unmodi?ed nanotubes. We therefore quanti?ed 
numbers of neurites/neuron, total neurite length/neuron, and 
numbers of branches/neurite in neurons groWn on nanotubes 
coated With 4-HNE, and neurons groWn on control nano 
tubes (See FIG. 2). Whereas neurons groWn on control 
nanotubes possessed only one or tWo neurites, those groWn 
on 4-HNE-modi?ed nanotubes elaborated 4—6 neurites. 
Total neurite length Was increased more than tWofold, and 
number of branches/neurite Were increased approximately 
threefold, in neurons groWn on 4-HNE-modi?ed nanotubes. 
These ?ndings demonstrate a striking effect of nanotube 
bound 4-HNE on neurite outgroWth, and establish the fea 
sibility of using chemically modi?ed carbon nanotubes as a 
tool for studying and manipulating neurite outgroWth. 
These ?ndings suggest the possibility that 4-HNE 
enhances adhesion of groWth cones to the nanotubes. Pre 
vious studies have shoWn that Ca2+ in?ux can regulate 
groWth cone motility and neurite elongation (Kater S. B., 
Mattson M. P., Cohan C., and Connor J. (1988) Calcium 
regulation of the neuronal groWth cone. Trends Neurosci. 11, 
315—321), and that 4-HNE can modulate intracellular Ca2+ 
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levels in cultured hippocampal neurons (Mark R. J ., Lovell 
M. A., Markesbery W. R., Uchida K., and Mattson M. P. 
(1997) A role for 4-hydroxynonenal in disruption of ion 
homeostasis and neuronal death induced by amyloid 
[3-peptide. J. Neurochem. 68, 255—264) as Well as in non 
neuronal cells (Carini R., Bellomo G., Paradisi L., DianZani 
M. U., and Albano E. (1996) 4-Hydroxynonenal triggers 
Ca2+ in?ux in isolated rat hepatocytes. Biochem. Biophys. 
Res. Commun. 18, 772—776). It is therefore possible that the 
neurite outgroWth-enhancing effect of 4-HNE involves 
changes in intracellular Ca2+ levels, although this remains to 
be established. 
The foregoing description of the preferred embodiment of 
the invention has been presented for purposes of illustration 
and description. It is not intended to be exhaustive or to limit 
the invention to the precise form disclosed. Obvious modi 
?cations or variations are possible in light of the above 
teachings. For example, a carbon nanotube may be substi 
tuted for a neuron in vivo. The embodiment Was chosen and 
described to provide the best illustration of the principles of 
the invention and its practical application to thereby enable 
one of ordinary skill in the art to utiliZe the invention in 
various embodiments and With various modi?cations as are 
suited to the particular use contemplated. All such modi? 
cations and variations are Within the scope of the invention 
as determined by the appended claims When interpreted in 
accordance With the breadth to Which they are fairly, legally 
and equitably entitled. 
What is claimed is: 
1. A cell and substrate system, comprising a carbon 
nanotube; and a mammalian embryonic hippocampal neuron 
groWing on said carbon nanotube. 
2. The system of claim 1, Wherein said carbon nanotube 
has a diameter of about 1.0—100.0 nm. 
3. The system of claim 2, Wherein said carbon nanotube 
has a length of betWeen about 20—100 pm. 
4. The system of claim 1, Wherein said carbon nanotube 
is functionaliZed With 4-hydroxynonenal. 
5. A carbon nanotube functionaliZed With 
4-hydroxynonenal. 
6. The carbon nanotube of claim 5, Wherein said carbon 
nanotube has a diameter of about 1.0—100.0 nm. 
7. The carbon nanotube of claim 6, Wherein said carbon 
nanotube has a length of betWeen about 20—100 pm. 
